CRLBF · Cresco Labs Inc.
$0.79
0.00 (-0.05%)
At close · Aug 17
Market Cap
$301.01M
Shares
372.35M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$655.85M
-9.5%
FY2025
Net Income
-$135.41M
-81.9%
FY2025
Gross Margin
49.49%
-0.8pp
FY2025
Operating Margin
-4.27%
-19.1pp
FY2025
Diluted EPS
-$0.38
-72.7%
FY2025
Operating Cash Flow
$72.89M
-45%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| $655.85M | $724.34M | $770.89M | |
| $331.28M | $359.89M | $408.52M | |
| $324.57M | $364.45M | $362.37M | |
| 49.49% | 50.32% | 47.01% | |
| $247.45M | $254.84M | $299.17M | |
| $6.39M | $7.11M | $7.05M | |
| $48.71M | $59.1M | $62.51M | |
| $352.56M | $257.16M | $450.19M | |
| -$27.99M | $107.29M | -$87.82M | |
| -4.27% | 14.81% | -11.39% | |
| $20.73M | $166.39M | -$25.31M | |
| $3.75M | $2.92M | $2.15M | |
| -$67.44M | -$117.91M | -$59.08M | |
| — | -$72K | -$500K | |
| -$95.42M | -$10.62M | -$146.9M | |
| $44.62M | $49.87M | $32.95M | |
| -$135.41M | -$74.44M | -$175.52M | |
| -20.65% | -10.28% | -22.77% | |
| -$4.64M | $13.95M | -$4.33M | |
| -$134.81M | -$75.52M | -$175.28M | |
| USD/shares | -$0.38 | -$0.22 | -$0.54 |
| USD/shares | -$0.38 | -$0.22 | -$0.54 |
| shares | 355.01M | 345.47M | 323.82M |
| shares | 355.01M | 345.47M | 323.82M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.65×
EV/EBIT
—
Peer median 13.54×
P/E (TTM)
—
Peer median 13.38×
Peer medians compare against the 54 similar-size Drug Manufacturers - Specialty & Generic companies (of 104 listed).